Average value of biopharma M&A deals worldwide 2010-2019, by industry
From 2010 to 2019, the average deal value of merger and acquisition deals worldwide involving biotech companies stood at some 1.63 billion U.S. dollars. This statistic illustrates the average deal value of biopharma M&A deals worldwide from 2010 to 2019, by industry.